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Abstract
Genome-wide association studies have been able to identify disease associations with many common variants; however
most of the estimated genetic contribution explained by these variants appears to be very modest. Rare variants are
thought to have larger effect sizes compared to common SNPs but effects of rare variants cannot be tested in the GWAS
setting. Here we propose a novel method to test for association of rare variants obtained by sequencing in family-based
samples by collapsing the standard family-based association test (FBAT) statistic over a region of interest. We also propose a
suitable weighting scheme so that low frequency SNPs that may be enriched in functional variants can be upweighted
compared to common variants. Using simulations we show that the family-based methods perform at par with the
population-based methods under no population stratification. By construction, family-based tests are completely robust to
population stratification; we show that our proposed methods remain valid even when population stratification is present.
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Introduction
It is now widely accepted that many diseases are caused by a
complex interplay between multiple genes and other non-genetic
factors, and that different genetic susceptibility factors may be
responsible for disease risks in different individuals. Genome-wide
association studies have been able to identify many variants
associated with complex diseases that are common in the
population. However most of the estimated genetic contribution
explained by these common variants appears to be very modest.
On the other hand, rare variants are thought to have a larger
effect size compared to common SNPs [1]. Availability of
sequencing data from specific candidate genes and functional
genomic regions such as exons for a large number of individuals
and from whole genome for a smaller set of individuals [2], has
made it possible to gain a wealth of information about the
potential effect of multiple rare variants on complex phenotypes.
Conventional statistical methods for common variants have low
power for low frequency SNPs, particularly when the power relies
on the linkage disequilibrium (LD) between the causal variants and
the observed markers.
To overcome the problem of poor power of the single SNP
strategy, the strategy of collapsing rare variants over a gene and
collective analyses of their association has been adopted.
Morgenthaler et al [3] devised the CAST (cohort alleleic sum
test) which collapses over the rare variants and then compares the
total rare variant frequency between cases and controls. Li and
Leal [4] extended the CAST method to come up with CMC
(combined multivariate and collapsing) method where collapsing is
done within different subgroups defined by allele frequencies and
combined using a multivariate distance-based statistic. All these
methods use a fixed threshold for specifying rare variants i.e. the
user must define a value for allele frequency to distinguish between
rare and common variants.
Madsen and Browning [5] proposed a method whereby variants
of any frequency can be included, but the variants are weighted
according to their frequencies - thus allowing rare variants to
contribute more to the test statistic than they do in the unweighted
case. Price et al [6] proposed a variable threshold approach,
designed to eliminate the need of choosing a fixed threshold to
include variants and showed that this method can be more
powerful compared to the fixed threshold approach. Moreover
they also proposed ways to include information about functional
impact of the variants. Hoffmann et al [7] introduces weights
which can incorporate allele frequency, direction (deleterious or
protective) and threshold all in a single analysis. More recently Lin
and Tang [8] proposed a general framework based on appropriate
regression methods to cover a wide range of study designs.
More recent methods deal with some of the more complex
issues of pooled rare variant analysis. Zhu et al [9] uses a
haplotype-based method to identify relevant rare haplotypes
associated with the disease. Hoffmann et al [7] uses a ‘step-up’
approach similar to forward selection to identify an optimal
grouping of rare variants. Ionita-Laza et al [10] suggests a
replication-based weighted-sum statistic which is applied separate-
ly to potential risk variants (those with observed higher frequency
in cases compared with controls) and potential protective variants,
and Neale et al [11] tailored the C-alpha [12] score test to test for
rare variants association - both of the two methods can address the
case where variants have different direction of effects on the same
genetic region. Lin and Tang [8] introduce a general score-based
test for population-based samples, that unifies many of these
approaches.
Even though there is a considerable sum of literature on
methods for rare variant analysis, few discuss family-based designs.
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Family-based analysis for single SNP association uses information
about transmission of genetic factors within families and has been
shown to potentially have more power than the population-based
design for rare diseases [13]. Moreover the family-based design is
robust to any bias induced by population substructure. For rare
variants this issue of population stratification is even more acute as
rare variants may include young mutations that are more
population-specific [2,14]. In this paper we propose a novel
method to test for association of rare variants in family-based
design by extending the traditional single SNP Family-Based
Association Test. To include both common and rare variants in
our analysis, we introduce suitable weighting schemes to upweight
rarer variants and downweight the more common variants. We
also evaluate the analysis using a fixed threshold value to identify
the rare variants. Finally we compare performance of these
methods under different settings against the fixed threshold version
of the population-based score statistic by Lin and Tang [8] and the
population-based weighted sum statistic by Madsen and Browning
[5].
Our approach builds on the FBAT multimarker test [15], which
is a ‘gene-based test’ designed for testing multiple SNPs from a
GWAS or candidate gene strictly. The proposed test is also similar
to FBAT-LC statistic, [16] which was designed for powerful and
efficient multimarker testing for measured phenotypes. Relation-
ship among these statistics are discussed in the subsequent section.
Methods
Family-based Association Test
We first consider a sample of n trios - one offspring with
information on both parents available and review the single
variant setting. The general FBAT statistic is a covariance between
the offspring genotype and trait. Let Xi and Yi denote the
genotype for the variant and the trait, respectively, for the ith
offspring. In the general case, Yi can be both measured or
dichotomous, and we can use an offset m to appropriately center
the trait [17]. For family samples with dichotomous traits such as
affected trios or discordant sibpairs, m is often taken to be zero;
with measured outcomes, mean of the outcome is usually chosen
for offset. For the additive model, Xi is the number of copies of





E(Xi DPi) in (1) is computed using Mendel’s laws under the null
hypothesis of no association and conditional on the trait as well as
the parental genotypes (denoted as Pi for the i-th family). Under
the same conditional distribution, we can compute Var(Xi DPi); the









2Var(Xi DPi). Under the null
hypothesis of no association Z is approximately N(0,1). The
formula extends easily where multiple offspring are sampled in a
family for testing the null hypothesis of no association and no
linkage.
The FBAT Multi-Marker test is a multivariate extension of the
univariate FBAT test designed to simultaneously test a set of
markers in a defined region, such as a gene. It belongs to the
general class of ‘gene-based tests’ since a set of M univariate tests
in a gene are replaced by a single multivariate test. Let Us and Zs
denote the statistics in equation 1 and 2, defined for the sth marker.
Assuming large samples to obtain sufficient heterozygote parents,
each Zs is approximately N(0,1), but the M markers may be
correlated because of linkage disequilibrium in the region.
Provided we have an estimate of the correlation matrix, we can
obtain a M degree of freedom test of the null hypothesis of no
association between any of the M variants and the disease, versus
the alternative that at least one marker is in LD with a disease
locus.
Rakovski et al [15] estimate the correlation matrix empirically
as follows: Let UMM~(U1, . . . ,UM ) be the vector of FBAT
statistics, which forms the basis of the multimarker test. Let VE ,







~1 . . .M





ing adjusted variance matrix VA is defined by
VA~D
1=2½Diag(VE){1=2VEDiag(VE){1=2D1=2:
Note that VE is a variance-covariance matrix, with all elements
estimated empirically. However the diagonal elements of VE can
be calculated directly provided there is no linkage between any
marker and the true disease locus. VA is an ‘adjusted’ variance
covariance matrix which replaces the empirical variances with the




In large samples, T will be approximately x2 distributed with
degrees of freedom equal to the rank of VA. The asymptotic
normality relies on the asymptotic normality of each marker test
Us, and may not be valid in the rare variant setting.
Several papers have noted that tests of multiple markers can be
greatly improved upon by taking optimal linear combinations of
the individual tests [8,16,18,19], but a major issue is determining
the optimal weights, since the optimal weights depend upon the
unknown effect of each marker. Xu et al [16] proposed a method
to handle this problem by using that portion of the family data that
is not used in constructing the FBAT statistics, e.g. the
noninformative families [13,20]. The approach is designed for
measured outcomes, or at least cases where both affected and
unaffected offspring are sampled. The approach can be extended
in principle to the setting where we have only affected trios [21],
but this is beyond the scope of this paper. An additional feature of
the FBAT-LC approach is that estimation of the weights can be
invalidated by population substructure.
Collapsing Method for Rare Variants
We extend the general FBAT statistic to test for rare variants by
using the approach of collapsing over a gene or a particular
genetic region. We assume that any variants associated with the
trait have effects in the same direction. Let Us be the FBAT
Rare Variant Analysis for Family-Based Design
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statistic corresponding to the sth variant and M be the total





where Xis is the number of copies of s
th variant in ith offspring.





















which is essentially a covariance between the trait and total



















The V (XisDPis)’s are the variances of each of the M SNPs
conditional on the trait and the parental genotypes; they can be
computed under the null hypothesis of no association simply using
Mendel’s laws as applied to the transmission probabilities.
As previously discussed, Cov(Xis,Xis0 DPis,Pis0 ) can be estimated
empirically using the variance estimator for multimarker FBAT
statistic. One advantage of using this method is that it avoids
haplotype reconstruction. As W can be expressed as 1TUMM , a
suitable estimate for Var(W) is 1TVA1= the sum of all elements in






is approximately N(0,1) in large samples under the null hypothesis
of no association. Note that asymptotic normality here only relies
on the normality of W, which should hold in the rare variant
setting provided the number of variants in the tested region is not
small.
Extension of the test statistic for other nuclear family structures
is straightforward. For a large multi-generation pedigree, the
simplest strategy would be to break the pedigree into nuclear
families and combine the contribution from all those nuclear
families. For example, the general FBAT statistic for the sth variant







where the summand corresponds to the jth offspring of the ith
family. We can use this statistic to get the collapsed statistic
W~
PM
s~1Us. When partial or no information is available on the
parental genotype, E(Xijs) and Var(Xijs) are computed conditional
on the trait values as well as the sufficient statistics for parental
genotypes. Note that the computation of variance in such cases
follows directly from computation of the variance estimator for
multimarker FBAT statistic. In this paper we will consider the
analysis for two common family designs - trios and discordant
sibpairs (DSP).
Weighting Scheme
When the region of interest contains both common and rare
variants, improvement in the performance of the statistic in
detecting effects of very low frequency variants will require
choosing a suitable weighting scheme that would upweight the
variants with lower frequencies. If the sth variant is assigned the






For our purpose we use two sets of weights : 1) ws = (# of
informative families for sth variant){1, where informative families
for trios are defined as families with at least one of the parents





where n is the total number of nuclear families and ps is the allele
frequency for sth variant estimated from the sample. The latter
weighting method is similar to the weighting scheme used by
Madsen and Browning [5] where they estimate the allele
frequencies from the control population. As argued in context of
their method, the weight of a variant is inversely proportional to
the estimated standard deviation of the number of alleles of the
corresponding marker in a random sample selected from the
population under the null distribution of no association. In this
case, for trios, allele frequencies are estimated from parents, and
for discordant sibpairs, allele frequencies are estimated from all
siblings. The weights in both cases are independent of the
transmissions used in the test statistic since they depend only on
parental genotypes, or the sufficient statistics for parental
genotypes in the case of discordant sibpairs [22]. Implicitly these
weights assume all markers have effects of the same sign, and that
the magnitude of the effect increases as corresponding allele
frequency decreases.
Weighting schemes other than these two options can also be
used if external information is available about the SNPs. Price et al
[6] suggested using functional predictions about the SNPs using
Polyphen-2 [23] scores to weight the SNPs. Similarly SIFT [24] or
other functional prediction scores can also be incorporated to
compute weights.
As discussed previously, Xu et al [16] also proposed a
weighted linear combination of FBAT statistics (FBAT-LC) in
the context of finding an optimal test for associating a set of
SNPs with a quantitative trait. This is similar to what Lin and
Tang [8] propose for estimating the effect of each SNP, except
the weights are estimated independently of the test statistics by
regressing the trait on the expected marker score using the
conditional mean model [13]. FBAT-LC is not available for
trios with affected only, but would make an attractive extension
Rare Variant Analysis for Family-Based Design
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for the setting where the effects of disease SNPs vary sign as
well as magnitude.
Fixed Threshold Approach
When the region of consideration contains both rare and
common variants, instead of weighting the variants differently
based on their allele frequencies, we can also use a user-defined
threshold value based on allele frequencies to identify a subset of
variants as rare and consider analysing only that subset. The fixed












where Y(t) is the subset of SNPs that have allele frequencies less
than the threshold value t. Conventional values of t, used to define
rare variants, are 1% and 5%. In this case, we assume that only
rare variants are associated with the trait - however the analysis
depends on a suitable choice of threshold value.
Simulation
The simulations are based on the assumption that variants in
the region of interest are under weak purifying selection and
Wright’s distribution is used to sample frequency for each variant
f (p)~cpB1{1(1{p)B2{1es(1{p)
where B1,B2 are scaled mutation rates and s is the selection rate.
We take B1~0:001,B2~B1=3 and s~12 as in Madsen and
Browning [5]. We fix the number of variants in the region to be 50
and we randomly select the DSVs out of the variants that have
frequency less than 1%. We choose the number of DSVs to be 10
or 20.
We generate the binary trait using a relative risk model for the
DSVs. We assume





where Xis is the number of copies of s
th variant in ith individual
and q is the number of DSVs. We examine two set-ups - in the first
set-up all variants have equal bs’s. In the second set-up we vary the
effect of the DSVs within a range of values exponentially such that
a lower frequency DSV is associated with a higher effect - we use
the formula bs~azbps for a value of a and b (v0), where ps is
the s-th variant frequency.
We generate samples from the trio design as well as sibpairs. We
generate parental haplotypes using the frequencies for the variants
assuming the variants to be independent. Once the parental
haplotypes are generated offspring haplotypes are generated from
the parental haplotype assuming no recombination between the
variants. Once offspring haplotypes are generated we only use the
genotypic data for simulating the disease status as well as for the
analysis. For the trio design we use offset m~0 i.e. only affected
offspring are used in our analysis and the total number of affected
offspring is fixed (n~500,1000). Similarly for sibpairs we only use
discordant sibpairs in the analysis, fixing the total number of
discordant sibpairs (n~500,1000). For the case-control design, we
use the affected offspring (generated for the trio design) as cases
and select an equal number of controls from the unaffected
offspring (from different families).
For analysis we use both the fixed threshold approach and the
no threshold approach. In this paper we use 0.5%, 1% and 5% as
cutoff values for fixed threshold analysis where the true DSVs have
frequencies less than 1%. Performance of the FBAT-multimarker
(FBAT-MM) is also evaluated as a fixed threshold test for these
threshold values. Note that since FBAT-MM is a multivariate test,
it’s not straightforward to construct a weighted version of the test
statistic. For the no threshold approach, we analyze all variants in
the region of interest. We evaluate performance of our method
under the trio design as well as the sibpair design and compare the
method against the fixed threshold method by Lin and Tang [8]
and a modified version of the weighted-sum statistic by Madsen
and Browning [5] for the case-control design. For both the case-
control methods, frequency of the variants is estimated using both
cases and controls based on recommendation by Lin and Tang [8]
- it should be noted that this method of estimating frequency is
different from traditional way used in Madsen and Browning [5]
which uses only controls to estimate allele frequency. We compare
both type-1 error as well as power under different settings.
Moreover we also investigate the effect of population stratifi-
cation which is potentially a problem for rare variants analysis. To
introduce stratification, first we simulate two subpopulations with
different distribution for the risk variants - for the first
subpopulation DSV allele frequencies are generated from the
Wright’s distribution above and for the second population
corresponding frequencies for DSVs are generated using the
Balding-Nichols model, [25] ensuring that the expected value of
the fixation index (FST) of the population is 0.01 or 0.05 - only the
results related to FST=0.01 is shown here as FST=0.05 is a more
extreme case of population stratification. Next, different values for
the baseline risk or eb0 =0.05 or 0.01 are used for the two
subpopulations.
Results
Among the two weighting schemes, weighting by allele
frequency estimates performs substantially better than weighting
by number of informative families, so we only display results
related to the former. Table 1 contains descriptive statistics for
estimates of prevalence (P(Y= 1)) and total population attributable
rate (PAR) for all 50 variants, computed from 500 simulations
using 500 cases and 500 controls. Note that we use the affected
offspring (generated for the trio design) as cases and select an equal
number of controls from the unaffected offspring (from different
families). Total PAR for the genetic region is defined as the sum of
PARs over all DSVs, where
PAR(variant)~
P(variant in cases) - P(variant in controls)
1-P(variant in controls)
:
It can be seen that the overall prevalence is very close to 0.05,
the baseline risk value used in the simulation and the estimated
average PAR is between the range 0–0.05.
Table 2 compares the type-1 error for the family-based methods
for fixed threshold (unweighted) and no threshold (weighted by
allele frequencies) with the corresponding case-control based
methods (Lin and Tang [8] method and the modified version of
Madsen-Browning [5] respectively) and the FBAT-MM test. At
the 5% and 1% level with no population stratification all the tests
controlled the type-1 error well. The Q-Q plots (not shown here)
suggested that type-1 error was controlled at lower levels as well.
However when population stratification was introduced, all the
population-based statistic had a significantly high false positive
rate. For family-based tests, the p-values were well-controlled. The
type-1 errors were also well controlled under the sibpair design
Rare Variant Analysis for Family-Based Design
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(not shown here). FBAT-MM is very conservative; at alpha of
0.05, the degree of conservativeness increases as the threshold
lowers.
Figure 1 displays relative performance of the methods when no
population stratification is present and effects of all the DSVs are
equal. The number of affected subjects in these simulations is 500.
For the fixed threshold method, using a lower threshold value
(0.5%) in contrast to using the true threshold for DSV (1%) incurred
lower power in all settings for the unweighted method. Analysis
using a higher threshold value (5%) performed at par with and in
some setting better than analysis using the true threshold value (1%).
FBAT-MM method performed slightly better compared to the
proposed family-based methods when magnitude of the effect was
higher. Performance of the proposed family-based methods were
similar to the case-control method for the fixed threshold approach
and better than the case-control method when weighted methods
were used. Under admixture, the power of the case-control methods
increase due to the anti-conservativeness, but the power of the
family-based methods is unchanged (Figure S1).
Figure 2 shows the power in the case where the effect size of an
allele is inversely related to it’s frequency. The results are generally
unchanged, and the higher power of the 5% threshold is clearly
present for both family and case-control designs. Figure 3 shows
the results for 1000 trios and 1000 cases. The power is higher as
expected, and the general trends seen for 500 trios or cases are the
same, except that the difference between the 1% and 5%
thresholds are now much smaller. The 0.5% threshold continues
to have low power. This suggests that the higher power for the 5%
threshold is due to sampling error in the estimation of allele
frequency; the threshold is compared to the estimated sample
frequency. Under H0, the probability that an allele frequency of
1% would be estimated as greater than 1% with 500 trios is quite
low, but will increase under selection of cases only when the
alternative hypothesis is true, especially for higher effect sizes. In
general, the power of the threshold approaches depend strongly on
the selected threshold, the no threshold weighted methods were at
a par with the best of the threshold approaches, and the family and
case-control designs showed little difference in power. The results
for the sib-ship design (Figures S4, S5) show that it has
considerably lower power than the trio design, as we might expect
from previous comparisons in the case of common DSVs [13].
Discussion
In this paper we present a family-based method designed
specifically for rare variants. Family-based design are robust from
bias due to population substructure and is particularly useful for
rare variant analysis since the issue of population stratification is
more prominent for rare variants. Moreover since genotyping
error rates are still substantially high for sequencing technologies,
family-based design provides the additional advantage of checking
for Mendelian error [26,27]. Power simulations show that the
proposed methods perform reasonably well compared to existing
population-based methods. Both the weighted and the unweighted
methods for family-based design preserves the type 1 error when
population stratification is present.
Analysis of rare variants can be approached as a separate
problem from analysis of common variants i.e. after analysis of all
common variants in a genetic region, only rare variants can be
analyzed to look for an association signal. In this paper the
performance of unweighted method using a fixed threshold
approach illustrates the situation where a select group of rare
variants are analyzed. However the performance of the fixed
threshold approach is highly dependent on the choice of the
Table 1. Mean and standard deviation of estimates of
prevalence and population attributable fraction(PAR) from
500 simulations for different values of the true relative risk
(RR) associated with a variant, # of cases = 500 and no
population stratification.
DSV RR(X:s)( = e
bs )
Prevalence
[Mean (SD)] PAR [Mean(SD)]
10 1 0.050(0.002) & 0(0.005)
2 0.051(0.002) 0.012(0.010)
3 0.052 (0.003) 0.024 (0.016)




Table 2. Type-1 error using normal cut-off at 0.05 and 0.01 level for 500 trios.
b0~ log (0:05)No population stratification,





0.005 0.01 0.05 0.005 0.01 0.05 0.005 0.01 0.05
0.05 0.050 0.046 0.046 0.014 0.020 0.030 0.048 0.052 0.054 0.050 0.028
0.01 0.006 0.010 0.010 0.002 0.002 0.002 0.008 0.004 0.010 0.006 0.008
Population stratification, b0,Pop1~ log (0:05),b0,Pop2~ log (0:01), FST =0.01





0.005 0.01 0.05 0.005 0.01 0.05 0.005 0.01 0.05
0.05 0.048 0.042 0.048 0.018 0.037 0.033 0.260 0.220 0.106 0.048 0.092
0.01 0.014 0.008 0.020 0 0.002 0 0.100 0.086 0.036 0.008 0.034
*Threshold values 0.005, 0.01 and 0.05 were used for the fixed threshold methods.
doi:10.1371/journal.pone.0048495.t002
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threshold value and such dependence remains even when a
weighting scheme is applied along with the fixed threshold (not
shown here). Choice of a threshold value which is lower than the
true threshold value (i.e. the cutoff for the true DSVs) incurs
substantially low power in almost all settings. The choice of the
optimal threshold depends upon the unknown allele frequency and
effect size of the DSLs, as well as the sample. The weighted no
threshold approach avoids such choice problem. Moreover when a
suitable weighting scheme is used, the no threshold approach
performs at par with and sometimes better than the best
performing fixed threshold approach, especially when the variants
have unequal effects. This approach always outperformed the
corresponding no threshold case-control method i.e. the modified
Madsen-Browning approach. Hence we recommend using a
weighted approach with no threshold in the absence of any prior
knowledge about the frequency of the DSVs.
In this paper we have used a weighting scheme based on allele
frequency but other weighting schemes based on functional
information can also be used. It should be noted that, even
though in this paper we suggest a few different weighting schemes,
Figure 1. Power at 0.05 level for trios and case-control design - No population stratification is present and b0~ log (0:05). # of
cases = 500. DSV’s have frequency less than 0.01 and equal effects. FT.fam - trios with fixed threshold method using threshold 0.005, 0.01 and 0.05,
FT.MM - FBAT-MM test using threshold 0.005, 0.01 and 0.05, FT.CC - case-control with unweighted method using threshold 0.005, 0.01 and 0.05,
NT.fam - trios with weighted method using no threshold, NT.CC - case-control with Madsen and Browning method.
doi:10.1371/journal.pone.0048495.g001
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the optimal weighting scheme is unknown and dependent on the
underlying disease model. The user can possibly use an omnibus
test, where p-values are minimized over different choices of
weighting schemes. Another alternative to the fixed threshold
method can be using the variable threshold method suggested by
Price et al [6] but this would involve a permutation-based test
which can be complicated for ascertained family-based samples.
As noted earlier, our method uses similar components as the
FBAT multimarker test but there are a few key differences. FBAT-
MM was designed to analyze GWAS data or a fixed region such as
candidate genes. Since the degree of freedom in FBAT-MM test is
the number of markers being analyzed, power of this test may be
adversely affected when applied on sequence data with high
number of variants. In addition, the multimarker test statistic
requires a stricter assumption of normality compared to our
proposed method and seemed to be quite conservative in terms of
type-1 error under low threshold values. Despite these caveats,
FBAT-MM performed very well in the fixed threshold setting. An
attractive extension would be to develop a weighted method for
the no threshold approach. This should work especially well in the
setting where the DSL’s have both positive and negative effects.
A major issue associated with any collapsing based method is
the issue of variants in a region having different direction of effect
on the trait. This paper focuses only on the situation where all the
variants have effect in the same direction. However, if there are
variants with opposite direction (a mix of deleterious and
protective variants) the collapsing method can lead to lower
power. It should be noted that this particular case might have less
impact on the power of FBAT-MM. One way of improving upon
the proposed family-based statistic could be to construct two
different statistic for the two different direction of variants based
on the sign of their estimated effects, following the strategy used by
Ionita-Laza et al [10]. This issue has not been addressed within
the scope of this paper however it warrants further investigation.
Most rare variant association analyses are largely motivated by
the idea that variants under 1–5% allele frequency have a higher
proportion of functional variants [28]. Hence we assume that the
disease suseptibility variants have allele frequency less than 1%.
This is, however, an extreme case of alleleic heterogeneity and in
more realistic situation common variants can also be DSV’s.
Performance of the method has been illustrated in this paper for
binary traits only - however we can easily extend the method for
quantitative traits. For this setting permutation testing strategies
are also available which is beyond the scope of this paper.
Moreover in this paper, we have not discussed any existing
methods for correcting bias due to population stratification for
population-based methods. Most of these methods (e.g. principal
component correction) have been originally developed for
genome-wide association studies and could be extended to
sequence data in principle. But feasibility of these methods for
small genetic region has not been studied in detail. Moreover a
recent study [29] suggests that for rare variants these existing
method show suboptimal performance in correcting for population
stratification.
In this paper we only analyze nuclear families and we
estimate variance of the test statistic using empirical estimates
for covariance between markers summing the contributions
from the nuclear families. This estimation method can be
inefficient when the method is being used for a multi-generation
pedigree [30] or distant set of relatives. Secondly, we have used
an additive model for SNPs for the analysis - other models
(dominant or recessive) need to be investigated as well. Since for
rare variants dominant and additive models tend to be very
similar, we suspect the trends to be similar as well. For recessive
models, we suspect the power of all the methods to be smaller,
except when the true disease model is recessive. Thirdly, our
results show that the trio design is more powerful than a
balanced case-control design with equal number of cases but the
discordant sibpair design is far less powerful. This will incur a
higher genotyping cost for nuclear families compared to
population-based methods to achieve comparable power.
Figure 2. Power at 0.05 level for trios and case-control design - No population stratification is present and b0~ log (0:05). # of
cases = 500. DSVs have frequency less than 0.01 and varying effects. FT.fam - trios with fixed threshold method using threshold 0.005, 0.01 and 0.05,
FT.CC - case-control with unweighted method using threshold 0.005, 0.01 and 0.05, NT.fam - trios with weighted method using no threshold, NT.CC -
case-control with Madsen and Browning method.
doi:10.1371/journal.pone.0048495.g002
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Both the unweighted and weighted method for rare variants are
included as options in the FBAT package. It is currently available
as beta release and will be officially released soon in the future.
Supporting Information
Figure S1 Power at 0.05 level for trios and case-control
design - Mixture of two subpopulations,
b0,Pop1~log(0:05), b0,Pop2~log(0:01), FST=0.01. # of cas-
es = 500. DSV’s have frequency less than 0.01 and equal effects.
FT.fam - trios with fixed threshold method using threshold 0.005,
0.01 and 0.05, FT.CC - case-control with unweighted method
using threshold 0.005, 0.01 and 0.05, NT.fam - trios with weighted
method using no threshold, NT.CC - case-control with Madsen
and Browning method. It should be noted that the inflated power
for case-control methods are also associated with inflated type-1
error under population stratification.
(DOC)
Figure S2 Power at 0.05 level for trios and case-control
design - Mixture of two subpopulations,
b0,Pop1~log(0:05), b0,Pop2~log(0:01), FST=0.01. # of cas-
Figure 3. Power at 0.05 level for trios and case-control design - No population stratification is present and b0~ log (0:05). # of
cases = 1000. DSV’s have frequency less than 0.01 and equal effects. FT.fam - trios with fixed threshold method using threshold 0.005, 0.01 and 0.05,
FT.CC - case-control with unweighted method using threshold 0.005, 0.01 and 0.05, NT.fam - trios with weighted method using no threshold, NT.CC -
case-control with Madsen and Browning method.
doi:10.1371/journal.pone.0048495.g003
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es = 500. DSVs have frequency less than 0.01 and varying effects.
FT.fam - trios with fixed threshold method using threshold 0.005,
0.01 and 0.05, FT.CC - case-control with unweighted method
using threshold 0.005, 0.01 and 0.05, NT.fam - trios with weighted
method using no threshold, NT.CC - case-control with Madsen
and Browning method. It should be noted that the inflated power
for case-control methods are also associated with inflated type-1
error under population stratification.
(DOC)
Figure S3 Power at 0.05 level for trios and case-control
design - Mixture of two subpopulations,
b0,Pop1~log(0:05), b0,Pop2~log(0:01), FST=0.01. # of cas-
es = 1000. DSV’s have frequency less than 0.01 and equal effects.
FT.fam - trios with fixed threshold method using threshold 0.005,
0.01 and 0.05, FT.CC - case-control with unweighted method
using threshold 0.005, 0.01 and 0.05, NT.fam - trios with weighted
method using no threshold, NT.CC - case-control with Madsen
and Browning method. It should be noted that the inflated power
for case-control methods are also associated with inflated type-1
error under population stratification.
(DOC)
Figure S4 Power at 0.05 level for discordant sibpairs -
No population stratification is present and b0~log(0:05).
# of cases = 500. DSV’s have frequency less than 0.01 and equal
effects. FT.fam - sibs with fixed threshold method using threshold
0.005, 0.01 and 0.05, NT.fam - sibs with weighted method using
no threshold.
(DOC)
Figure S5 Power at 0.05 level for discordant sibpairs -
Mixture of two subpopulations, b0,Pop1~log(0:05),
b0,Pop2~log(0:01), FST=0.01. # of cases = 500. DSV’s have
frequency less than 0.01 and equal effects. FT.fam - sibs with fixed
threshold method using threshold 0.005, 0.01 and 0.05, NT.fam -
sibs with weighted method using no threshold.
(DOC)
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